deferiprone has been researched along with Central Nervous System Disease in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with DFP proved safe and well tolerated." | 1.51 | Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study. ( Abbruzzese, G; Cossu, G; Forni, GL; Marchese, R; Matta, G; Oppo, V; Pinto, V; Ruffinengo, U, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cossu, G | 1 |
| Abbruzzese, G | 1 |
| Forni, GL | 1 |
| Matta, G | 1 |
| Pinto, V | 1 |
| Ruffinengo, U | 1 |
| Oppo, V | 1 |
| Marchese, R | 1 |
1 other study available for deferiprone and Central Nervous System Disease
| Article | Year |
|---|---|
Efficacy and safety of deferiprone for the treatment of superficial siderosis: results from a long-term observational study.
Topics: Aged; Brain; Central Nervous System Diseases; Deferiprone; Follow-Up Studies; Hemosiderin; Humans; I | 2019 |